Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-03-011306
Filing Date
2003-03-31
Accepted
2003-03-31 16:36:55
Documents
7
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2106640z10-k.htm 10-K 713374
3 EXHIBIT 10.50 a2106640zex-10_50.htm EX-10.50 49156
4 EXHIBIT 10.53 a2106640zex-10_53.htm EX-10.53 5989
5 EXHIBIT 10.54 a2106640zex-10_54.htm EX-10.54 6086
6 EXHIBIT 21.1 a2106640zex-21_1.htm EX-21.1 2317
7 EXHIBIT 23.1 a2106640zex-23_1.htm EX-23.1 1805
8 EXHIBIT 99.1 a2106640zex-99_1.htm EX-99.1 3405
  Complete submission text file 0001047469-03-011306.txt   784322
Mailing Address 2292 FARADAY AVE CARLSBAD CA 92008
Business Address 2292 FARADAY AVE CARLSBAD CA 92008 7609319200
ISIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19125 | Film No.: 03631334
SIC: 2834 Pharmaceutical Preparations